UCB Pharma

UCB SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is...

Founded in 1928
Total money raised: $100M

1070 Allée de la Recherche, 60


Phone: +32/2/559.99.99

Updated on Mar 30, 2013
UCB Pharma at CrunchBase
Roch Doliveux CEO
Detlef Thielgen CFO
Thomas R. Beck Corporate Vice President, Director of Global Research and Development
Andy Barrett Oracle DBA Documentum Administrator
Thomas R. Beck Director, R&D

October, 2010

UCB Pharma invested $30M in Synosia Therapeutics as a Series C round

June, 2010

UCB ups stake in oncology partner

December, 2009

UCB Pharma raised $100M in unattributed round from Paul Capital

Paul Capital Invests $100M In Belgian Pharma UCB In Royalty Deal


UCB Pharma was founded in 1928